CGEN Q2 2024 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

Q2 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$7M

Gross Profit

$5M76.8% margin

Operating Income

-$3M-50.9% margin

Net Income

-$2M-31.7% margin

EPS (Diluted)

$-0.02

QoQ Revenue Growth

+161.9%

Balance Sheet

Total Assets

$110M

Total Liabilities

$52M

Stockholders' Equity

$58M

Cash & Equivalents

$12M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$7M	$0	—
Gross Profit	$5M	$0	—
Operating Income	-$3M	-$10M	+66.6%
Net Income	-$2M	-$9M	+77.1%